We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $39.1B
1-Year Est. Return 15.14%
This Fund
S&P 500
This Quarter Est. Return
-11.46%
1 Year Est. Return
+15.14%
3 Year Est. Return
+57.14%
5 Year Est. Return
+86.44%
10 Year Est. Return
+281.86%
AUM
$16.6B
AUM Growth
-$2.56B
Cap. Flow
-$189M
Cap. Flow %
-1.14%
Top 10 Hldgs %
41.98%
Holding
251
New
10
Increased
48
Reduced
88
Closed
13

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$145M
2
SHW icon
Sherwin-Williams
SHW
+$33.7M
3
META icon
Meta Platforms (Facebook)
META
+$22.9M
4
AMZN icon
Amazon
AMZN
+$21.1M
5
MA icon
Mastercard
MA
+$17.9M

Top Sells

Rank Stock Value
1
PX
Praxair Inc
PX
+$160M
2
PM icon
Philip Morris
PM
+$52.2M
3
STT icon
State Street
STT
+$25.3M
4
AAPL icon
Apple
AAPL
+$19.5M
5
DIS icon
Walt Disney
DIS
+$17.3M

Sector Composition

Rank Sector Weight
1 Consumer Staples 25.44%
2 Financials 18.99%
3 Energy 14.69%
4 Technology 11.84%
5 Healthcare 10.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GS icon
226
Goldman Sachs
GS
$300B
$223K ﹤0.01%
1,337
-165
-11% -$33.3K
GWW icon
227
W.W. Grainger
GWW
$65.3B
$216K ﹤0.01%
+765
New +$228K
GM icon
228
General Motors
GM
$80.4B
$211K ﹤0.01%
6,300
CAG icon
229
Conagra Brands
CAG
$6.94B
$209K ﹤0.01%
9,766
SHPG
230
DELISTED
Shire pic
SHPG
$206K ﹤0.01%
1,185
MXIM
231
DELISTED
Maxim Integrated Products
MXIM
$205K ﹤0.01%
4,036
MMAT
232
DELISTED
Meta Materials Inc. Common Stock
MMAT
$201K ﹤0.01%
1,780
PR
233
Permian Resources
PR
$17.8B
$147K ﹤0.01%
13,350
F icon
234
Ford
F
$58.5B
$97K ﹤0.01%
12,699
WTI icon
235
W&T Offshore
WTI
$534M
$49K ﹤0.01%
11,858
ROX
236
DELISTED
Castle Brands, Inc.
ROX
$45K ﹤0.01%
52,830
PLXP
237
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$21K ﹤0.01%
13,729
NNVC icon
238
NanoViricides
NNVC
$38.8M
$6K ﹤0.01%
1,429
CFR icon
239
Cullen/Frost Bankers
CFR
$10.3B
-3,444
Closed -$360K
DVA icon
240
DaVita
DVA
$15.4B
-8,000
Closed -$573K
EQNR icon
241
Equinor
EQNR
$97.7B
-7,810
Closed -$220K
EXP icon
242
Eagle Materials
EXP
$6.29B
-2,625
Closed -$224K
GSK icon
243
GSK
GSK
$104B
-4,145
Closed -$208K
HHH icon
244
Howard Hughes
HHH
$3.81B
-1,827
Closed -$216K
RH icon
245
RH
RH
$3.13B
-100,000
Closed -$13.1M
FBSS
246
DELISTED
Fauquier Bankshares Inc
FBSS
-9,600
Closed -$243K
DNKN
247
DELISTED
Dunkin' Brands Group, Inc.
DNKN
-3,114
Closed -$230K
RTN
248
DELISTED
Raytheon Company
RTN
-1,064
Closed -$220K
AET
249
DELISTED
Aetna Inc
AET
-7,427
Closed -$1.51M
PX
250
DELISTED
Praxair Inc
PX
-993,441
Closed -$160M

Similar funds

Fayez Sarofim & Co's Q4 2018 Portfolio in Review

As of Q4 2018, Fayez Sarofim & Co held 251 positions worth $16.6B, down 13% from $19.1B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Fayez Sarofim & Co's Q4 2018 filing shows 10 new, 48 increased, 88 reduced and 13 closed positions. Its largest new stake was Linde: 915,945 shares worth $143M. The largest sale was Praxair Inc, an estimated $160M.

By sector, the portfolio is most concentrated in Consumer Staples at 25% of assets, up from 25% a quarter earlier, followed by Financials and Energy.

  • Fayez Sarofim & Co's largest Q4 2018 buy was Linde: 915,945 shares worth $143M.
  • Fayez Sarofim & Co added most to Sherwin-Williams in Q4 2018, an estimated $33.7M increase.
  • Fayez Sarofim & Co's biggest Q4 2018 reduction was Philip Morris, cutting an estimated $52.2M.
  • Fayez Sarofim & Co fully exited Praxair Inc in Q4 2018, selling an estimated $160M.
  • Fayez Sarofim & Co's ten largest holdings make up 42% of its $16.6B portfolio in Q4 2018.
  • Fayez Sarofim & Co opened 10 new positions and closed 13 in Q4 2018.
  • Fayez Sarofim & Co's portfolio value fell 13% quarter-over-quarter to $16.6B.

Based on Fayez Sarofim & Co's 13F filing for Q4 2018, filed 13 Feb 2019.